FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:68-69 July 5, 2001 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: The study by Freedberg et al. (March 15 issue)¹ compared a three-drug regimen with no antiretroviral therapy in patients infected with the human immunodeficiency virus (HIV) and found the regimen to be effective. One weakness of this study is that no treatment was chosen as the reference category. There were no comparisons between triple therapy and double therapy or between triple therapy and monotherapy. Studies of cost effectiveness should be guided by clinical research, and the controlled studies in the analysis by Freedberg et al. did not include untreated groups. Since withholding treatment is unethical, the design . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.